Study | Reason for exclusion |
---|---|
Afshari 2015 | Not an RCT |
Amarenco 2014 | Participants randomised within 14 days of stroke onset |
Asberg 2018 | Comparison of 2 anticoagulant regimens |
Bergmann 1996 | Not all participants had AIS |
Bradshaw 1975 | Non‐random: allocation by odd/even year of birth |
Camerlingo 2005 | Confounded by the use of low‐dose unfractionated heparin in control group |
Carter 1961 | Non‐random: alternate allocation |
Chang 2002 | No published data available |
Chen 2019 | Comparison of 2 anticoagulant regimens |
ChiCTR‐OIN‐17013510 | Not an RCT |
COU 9116 | Participants randomised within 14 days of stroke onset |
Coutinho 2015 | No anticoagulant |
Crepin‐leblond 1994 | Comparison of 2 anticoagulant regimens |
Czechanowski 1981 | Confounded with dihydroergotamine |
Dahan 1986 | Not all participants were stroke patients: individual patient data for stroke patients not available |
Dan 2001 | Methods of randomisation unclear; no clinically relevant outcomes reported |
DATAS II 2020 | Comparison of anticoagulant and antiplatelet |
Dehen 1994 | Control group received low‐molecular‐weight heparin plus placebo |
Diener 2005 | Comparison of 2 anticoagulant regimens |
Dong 2003 | No published data available |
Donnan 1996 | No anticoagulant |
Dumas 1994 | Comparison of 2 anticoagulant regimens |
Egan 1999 | Not an RCT |
Egberts 1996 | No published data available |
ELAN 2017 | Does not compare effects of anticoagulants |
EMT 1992 | Not an RCT |
Enger 1965 | Time from stroke to treatment unclear |
England 2010 | Not an RCT |
Eriksson 1983 | Non‐random: allocation by month of admission |
Fang 2015 | Study not conducted |
Fassbender 1998 | Comparison of 2 anticoagulant regimens |
Field 2017 | No published data available |
Fradley 2014 | Comparison of 2 anticoagulant regimens |
Geisler 2017 | Anticoagulant vs antiplatelet regimen |
Gelmers 1980 | Non‐random: alternate allocation |
Grond 2000 | Not an RCT |
HAEST 2000 | Anticoagulant vs antiplatelet regimen |
Hillbom 1999 | Comparison of 2 anticoagulant regimens |
Hillbom 2002 | Comparison of 2 anticoagulant regimens |
Hossman 1986 | No published data available |
Hui 2016 | No published data available |
IRCT2014020213698N1 | Comparison of 2 anticoagulant regimens |
IRCT201407213106N18 | No anticoagulant |
ISRCTN25644448 | Participant randomisation within 14 days of stroke onset |
Ji 2017 | Comparison of 2 anticoagulant regimens |
Jin 2017 | Comparison of 2 anticoagulant regimens |
JPRN‐UMIN000014405 | Did not explore the effect of anticoagulant |
JPRN‐UMIN000025392 | Randomisation over 14 days |
Kamel 2018 | Participants randomised within 14 days of stroke onset |
Kang 2010 | No clinical outcome data provided |
Kario 1995 | No clinically relevant outcomes reported |
Kataoka 2000 | Not an RCT |
Kim 2003 | Comparison of 2 anticoagulant regimens |
Kobayashi 1997 | No clinically relevant outcomes reported |
Lee 1994 | Confounded with urokinase |
Lee 2008 | Comparison of 2 anticoagulant regimens |
Lee 2014 | Did not involve anticoagulant as an intervention |
Liu 2015 | Anticoagulant vs antiplatelet regimen |
Lu 2001 | No published data available |
Luo 2013 | Comparison of 2 anticoagulant regimens |
McCarthy 1993 | Data not available despite repeated contact with study authors |
McDevitt 1959 | Time from stroke to treatment unclear |
Melero 2007 | Comparison of 2 anticoagulant regimens |
Meredit 2009 | Comparison of 2 anticoagulant regimens |
Moulin 1994 | Comparison of 2 anticoagulant regimens |
Muck 1997 | Comparison of 2 anticoagulant regimens |
NAVIGATE ESUS 2014 | Randomised between 7 days and 6 months after stroke onset |
NCT01924325 | Anticoagulant vs antiplatelet regimen |
NCT02221102 | Study not conducted |
NCT02283294 | Anticoagulant vs antiplatelet regimen |
NCT03961334 | Anticoagulant vs antiplatelet regimen |
OPTIMAS 2018 | Does not compare effect of anticoagulant but time of commencing anticoagulant |
PREVAIL 2004 | Comparison of 2 anticoagulant regimens |
RAPID 2005 | Anticoagulant vs antiplatelet regimen |
RESPECT CVT 2018 | Randomisation 5 to 15 days after initial acute treatment |
RE‐SPECT ESUS 2019 | Recruitment within 6 months of embolic stroke onset |
Rha 2001 | No published data available |
Rose 2019 | Comparison of 2 anticoagulant regimens |
Rosin 1994 | Data not available despite repeated contact with study authors |
Shi 2004 | No clinically relevant outcomes reported |
SOCRATES 2016 | Anticoagulant not an intervention |
Stiekema 1988 | No control group: dose‐finding trial |
TAIST 2001 | Anticoagulant vs antiplatelet regimen |
Tan 1998 | Not randomised; no clinically relevant outcomes reported |
Thygesen 1964 | Non‐random allocation |
Tomek 2011 | Comparison of 2 anticoagulant regimens |
Toni 2000 | Not an RCT |
Trencev 2008 | No published data available |
Triple AXEL 2015 | Comparison of 2 anticoagulant regimens |
Tsuchiya 1989 | Confounded with urokinase |
Tsuchiya 1990 | Confounded with urokinase |
Turpie 1991 | Comparison of 2 anticoagulant regimens |
Turpie 1992 | Comparison of 2 anticoagulant regimens |
VA Study 1961 | Treatment started acutely in only 50%; unable to get individual patient data for just these participants |
Warach 2003 | No published data available |
Wellington 2002 | Comparison of 2 anticoagulant regimens |
Wong 2000 | Comparison of 2 anticoagulant regimens |
Yamaguchi 2004 | Comparison of 2 anticoagulant regimens |
Yang 2016 | Anticoagulant not an intervention |
Yi 2015 | Anticoagulant vs antiplatelet regimen |
Zhang 2005 | Not clearly randomised |
Zhu 2014 | No published data available |
Zuo 2017 | Anticoagulant not an intervention |
AIS: acute ischaemic stroke
RCT: randomised controlled trial